The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middendorp, S.
Right arrow Articles by Hendriks, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middendorp, S.
Right arrow Articles by Hendriks, R. W.
The Journal of Immunology, 2003, 171: 5988-5996.
Copyright © 2003 by The American Association of Immunologists

Function of Bruton’s Tyrosine Kinase during B Cell Development Is Partially Independent of Its Catalytic Activity 1

Sabine Middendorp*, Gemma M. Dingjan*, Alex Maas{dagger}, Katarina Dahlenborg* and Rudolf W. Hendriks2,*

Departments of * Immunology and {dagger} Cell Biology and Genetics, Erasmus MC Rotterdam, Rotterdam, The Netherlands

The Tec family member Bruton’s tyrosine kinase (Btk) is a cytoplasmic protein tyrosine kinase that transduces signals from the pre-B and B cell receptor (BCR). Btk is involved in pre-B cell maturation by regulating IL-7 responsiveness, cell surface phenotype changes, and the activation of {lambda} L chain gene rearrangements. In mature B cells, Btk is essential for BCR-mediated proliferation and survival. Upon BCR stimulation, Btk is transphosphorylated at position Y551, which promotes its catalytic activity and subsequently results in autophosphorylation at position Y223 in the Src homology 3 domain. To address the significance of Y223 autophosphorylation and the requirement of enzymatic activity for Btk function in vivo, we generated transgenic mice that express the autophosphorylation site mutant Y223F and the kinase-inactive mutant K430R, respectively. We found that Y223 autophosphorylation was not required for the regulation of IL-7 responsiveness and cell surface phenotype changes in differentiating pre-B cells, or for peripheral B cell differentiation. However, expression of the Y223F-Btk transgene could not fully rescue the reduction of {lambda} L chain usage in Btk-deficient mice. In contrast, transgenic expression of kinase-inactive K430R-Btk completely reconstituted {lambda} usage in Btk-deficient mice, but the defective modulation of pre-B cell surface markers, peripheral B cell survival, and BCR-mediated NF-{kappa}B induction were partially corrected. From these findings, we conclude that: 1) autophosphorylation at position Y223 is not essential for Btk function in vivo, except for regulation of {lambda} L chain usage, and 2) during B cell development, Btk partially acts as an adapter molecule, independent of its catalytic activity.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. N. Miura, M. Komai, Y. Adachi, N. Osada, Y. Kameoka, K. Suzuki, and N. Ohno
IL-10 Is a Negative Regulatory Factor of CAWS-Vasculitis in CBA/J Mice as Assessed by Comparison with Bruton's Tyrosine Kinase-Deficient CBA/N Mice
J. Immunol., September 1, 2009; 183(5): 3417 - 3424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Sahu, C. Mueller, A. Fischer, and A. August
Differential Sensitivity to Itk Kinase Signals for T Helper 2 Cytokine Production and Chemokine-Mediated Migration
J. Immunol., March 15, 2008; 180(6): 3833 - 3838.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Irish, D. K. Czerwinski, G. P. Nolan, and R. Levy
Kinetics of B Cell Receptor Signaling in Human B Cell Subsets Mapped by Phosphospecific Flow Cytometry
J. Immunol., August 1, 2006; 177(3): 1581 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yu, A. J. Mohamed, L. Vargas, A. Berglof, G. Finn, K. P. Lu, and C. I. E. Smith
Regulation of Bruton Tyrosine Kinase by the Peptidylprolyl Isomerase Pin1
J. Biol. Chem., June 30, 2006; 281(26): 18201 - 18207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kersseboom, V. B. T. Ta, A. J. E. Zijlstra, S. Middendorp, H. Jumaa, P. Fokko van Loo, and R. W. Hendriks
Bruton's Tyrosine Kinase and SLP-65 Regulate Pre-B Cell Differentiation and the Induction of Ig Light Chain Gene Rearrangement.
J. Immunol., April 15, 2006; 176(8): 4543 - 4552.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Guo, M. I. Wahl, and O. N. Witte
Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families
Int. Immunol., January 1, 2006; 18(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Feldhahn, P. Rio, B. N. B. Soh, S. Liedtke, M. Sprangers, F. Klein, P. Wernet, H. Jumaa, W.-K. Hofmann, H. Hanenberg, et al.
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells
PNAS, September 13, 2005; 102(37): 13266 - 13271.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Feldhahn, F. Klein, J. L. Mooster, P. Hadweh, M. Sprangers, M. Wartenberg, M. M. Bekhite, W.-K. Hofmann, S. Herzog, H. Jumaa, et al.
Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells
J. Exp. Med., June 6, 2005; 201(11): 1837 - 1852.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Rajaiya, M. Hatfield, J. C. Nixon, D. J. Rawlings, and C. F. Webb
Bruton's Tyrosine Kinase Regulates Immunoglobulin Promoter Activation in Association with the Transcription Factor Bright
Mol. Cell. Biol., March 15, 2005; 25(6): 2073 - 2084.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Middendorp, A. J. E. Zijlstra, R. Kersseboom, G. M. Dingjan, H. Jumaa, and R. W. Hendriks
Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity
Blood, January 1, 2005; 105(1): 259 - 265.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.